267 related articles for article (PubMed ID: 28575206)
21. Galactocerebrosidase-deficient oligodendrocytes maintain stable central myelin by exogenous replacement of the missing enzyme in mice.
Kondo Y; Wenger DA; Gallo V; Duncan ID
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18670-5. PubMed ID: 16352725
[TBL] [Abstract][Full Text] [Related]
22. Identification of a microglia phenotype supportive of remyelination.
Olah M; Amor S; Brouwer N; Vinet J; Eggen B; Biber K; Boddeke HW
Glia; 2012 Feb; 60(2):306-21. PubMed ID: 22072381
[TBL] [Abstract][Full Text] [Related]
23. The Role of Galectin-3: From Oligodendroglial Differentiation and Myelination to Demyelination and Remyelination Processes in a Cuprizone-Induced Demyelination Model.
Hoyos HC; Marder M; Ulrich R; Gudi V; Stangel M; Rabinovich GA; Pasquini LA; Pasquini JM
Adv Exp Med Biol; 2016; 949():311-332. PubMed ID: 27714696
[TBL] [Abstract][Full Text] [Related]
24. TREM2-dependent microglial function is essential for remyelination and subsequent neuroprotection.
Wang Y; Kyauk RV; Shen YA; Xie L; Reichelt M; Lin H; Jiang Z; Ngu H; Shen K; Greene JJ; Sheng M; Yuen TJ
Glia; 2023 May; 71(5):1247-1258. PubMed ID: 36625077
[TBL] [Abstract][Full Text] [Related]
25. Delayed accumulation of activated macrophages and inhibition of remyelination after spinal cord injury in an adult rodent model.
Imai M; Watanabe M; Suyama K; Osada T; Sakai D; Kawada H; Matsumae M; Mochida J
J Neurosurg Spine; 2008 Jan; 8(1):58-66. PubMed ID: 18173348
[TBL] [Abstract][Full Text] [Related]
26. Diet-dependent regulation of TGFβ impairs reparative innate immune responses after demyelination.
Bosch-Queralt M; Cantuti-Castelvetri L; Damkou A; Schifferer M; Schlepckow K; Alexopoulos I; Lütjohann D; Klose C; Vaculčiaková L; Masuda T; Prinz M; Monroe KM; Di Paolo G; Lewcock JW; Haass C; Simons M
Nat Metab; 2021 Feb; 3(2):211-227. PubMed ID: 33619376
[TBL] [Abstract][Full Text] [Related]
27. The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia.
Mecha M; Yanguas-Casás N; Feliú A; Mestre L; Carrillo-Salinas F; Azcoitia I; Yong VW; Guaza C
Brain Behav Immun; 2019 Mar; 77():110-126. PubMed ID: 30582962
[TBL] [Abstract][Full Text] [Related]
28. TREM2-dependent lipid droplet biogenesis in phagocytes is required for remyelination.
Gouna G; Klose C; Bosch-Queralt M; Liu L; Gokce O; Schifferer M; Cantuti-Castelvetri L; Simons M
J Exp Med; 2021 Oct; 218(10):. PubMed ID: 34424266
[TBL] [Abstract][Full Text] [Related]
29. Social isolation impairs remyelination in mice through modulation of IL-6.
Makinodan M; Ikawa D; Miyamoto Y; Yamauchi J; Yamamuro K; Yamashita Y; Toritsuka M; Kimoto S; Okumura K; Yamauchi T; Fukami SI; Yoshino H; Wanaka A; Kishimoto T
FASEB J; 2016 Dec; 30(12):4267-4274. PubMed ID: 27613805
[TBL] [Abstract][Full Text] [Related]
30. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX
Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802
[TBL] [Abstract][Full Text] [Related]
31. The TAM receptor TYRO3 is a critical regulator of myelin thickness in the central nervous system.
Blades F; Aprico A; Akkermann R; Ellis S; Binder MD; Kilpatrick TJ
Glia; 2018 Oct; 66(10):2209-2220. PubMed ID: 30208252
[TBL] [Abstract][Full Text] [Related]
32. Lesion stage-dependent causes for impaired remyelination in MS.
Heß K; Starost L; Kieran NW; Thomas C; Vincenten MCJ; Antel J; Martino G; Huitinga I; Healy L; Kuhlmann T
Acta Neuropathol; 2020 Sep; 140(3):359-375. PubMed ID: 32710244
[TBL] [Abstract][Full Text] [Related]
33. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.
Tanaka T; Murakami K; Bando Y; Yoshida S
J Neurochem; 2013 Oct; 127(2):259-70. PubMed ID: 23647102
[TBL] [Abstract][Full Text] [Related]
34. Activation of FXR by ganoderic acid A promotes remyelination in multiple sclerosis via anti-inflammation and regeneration mechanism.
Jia Y; Zhang D; Li H; Luo S; Xiao Y; Han L; Zhou F; Wang C; Feng L; Wang G; Wu P; Xiao C; Yu H; Du J; Bao H
Biochem Pharmacol; 2021 Mar; 185():114422. PubMed ID: 33482151
[TBL] [Abstract][Full Text] [Related]
35. Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions.
Clarner T; Diederichs F; Berger K; Denecke B; Gan L; van der Valk P; Beyer C; Amor S; Kipp M
Glia; 2012 Oct; 60(10):1468-80. PubMed ID: 22689449
[TBL] [Abstract][Full Text] [Related]
36. The ApoA-I mimetic peptide 5A enhances remyelination by promoting clearance and degradation of myelin debris.
Vanherle S; Jorissen W; Dierckx T; Loix M; Grajchen E; Mingneau F; Guns J; Gervois P; Lambrichts I; Dehairs J; Swinnen JV; Mulder MT; Remaley AT; Haidar M; Hendriks JJA; Bogie JJF
Cell Rep; 2022 Nov; 41(6):111591. PubMed ID: 36351388
[TBL] [Abstract][Full Text] [Related]
37. Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system.
Rawji KS; Young AMH; Ghosh T; Michaels NJ; Mirzaei R; Kappen J; Kolehmainen KL; Alaeiilkhchi N; Lozinski B; Mishra MK; Pu A; Tang W; Zein S; Kaushik DK; Keough MB; Plemel JR; Calvert F; Knights AJ; Gaffney DJ; Tetzlaff W; Franklin RJM; Yong VW
Acta Neuropathol; 2020 May; 139(5):893-909. PubMed ID: 32030468
[TBL] [Abstract][Full Text] [Related]
38. The chemokine receptor CXCR2 is differentially regulated on glial cells in vivo but is not required for successful remyelination after cuprizone-induced demyelination.
Lindner M; Trebst C; Heine S; Skripuletz T; Koutsoudaki PN; Stangel M
Glia; 2008 Aug; 56(10):1104-13. PubMed ID: 18442092
[TBL] [Abstract][Full Text] [Related]
39. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
Zöller I; Büssow H; Gieselmann V; Eckhardt M
Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
[TBL] [Abstract][Full Text] [Related]
40. Restoration of FcRgamma/Fyn signaling repairs central nervous system demyelination.
Seiwa C; Yamamoto M; Tanaka K; Fukutake M; Ueki T; Takeda S; Sakai R; Ishige A; Watanabe K; Akita M; Yagi T; Tanaka K; Asou H
J Neurosci Res; 2007 Apr; 85(5):954-66. PubMed ID: 17290413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
